Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02771912Phase 4Completed
Phase 4, randomised, double-blind trial of propofol in cataract (2 arms), sponsored by Adolphe de Rothschild Foundation Hospital. Primary endpoint: Number of self-administered boluses at 1 day. Started Jul 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02771912.